Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “anti-”

1,068 pharma patents match "anti-" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,068
Index total 30,257
Page 36 / 45

Quick answer

This filtered view shows 1,068 pharmaceutical patents matching "anti-" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,068 results for “anti-” · 30,257 patents in full index Clear search

  1. US 8785409

    Compounds having anti-adhesive effects on cancer cells

    The Board of Regents of the University of Texas System · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  2. US 8772247

    Anti-parasitic compounds

    The Regents of the University of California · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted

  3. US 8771706

    Anti-RSV immunogens and methods of immunization

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted

  4. US 8734799

    Unconjugated anti-TfR antibodies and compositions thereof for the treatment of cancer

    The Regents of the University of California · Granted May 27, 2014 · Expires May 22, 2034

    granted

  5. US 8728493

    Polymer based compositions and conjugates of non-steroidal anti-inflammatory drugs

    Nektar Therapeutics · Granted May 20, 2014 · Expires May 15, 2034

    granted

  6. US 8728458

    Combination anti-HIV vectors, targeting vectors, and methods of use

    The Regents of the University of California · Granted May 20, 2014 · Expires May 15, 2034

    granted

  7. US 8722616

    Anti-HIV peptides and methods of use thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted May 13, 2014 · Expires May 8, 2034

    granted

  8. US 8716030

    Means for the inhibition of anti-β1-adrenergic receptor antibodies

    Julius-Maximillians-Universitat Wurzburg, A Germany University · Granted May 6, 2014 · Expires May 1, 2034

    granted

  9. US 8716265

    4-quinolinemethanols as anti-malarial agents

    Jenrin Discovery, LLC · Granted May 6, 2014 · Expires May 1, 2034

    granted

  10. US 8715682

    Means for the inhibition of anti-beta1-adrenergic receptor antibodies

    Julius-Maximillians-Universitat Wurzburg, A Germany University · Granted May 6, 2014 · Expires May 1, 2034

    granted

  11. US 8710026

    MiR 204, miR 211, their anti-miRs, and therapeutic uses of same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  12. US 8697666

    Anti-cancer oligodeoxynucleotides

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  13. US 8658616

    Nucleoside aryl phosphoramidates and their use as anti-viral agents for the treatment of hepatitis C virus

    University College Cardiff Consultants Limited · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted

  14. US 8642604

    Substituted pyrazolo[3,2-d]pyrimidines as anti-cancer agents

    The Regents of the University of California · Granted Feb 4, 2014 · Expires Jan 30, 2034

    granted

  15. US 8642784

    Biologically active compound N-[3-(4-nitrophenylamino)-indole-2-ilmethylene]aminoguanidine hydrochloride with anti-inflammatory activity

    Obschestvo S Ogranichennoy Otvetstvennostyu “Polyar” (OOO Polyar) · Granted Feb 4, 2014 · Expires Jan 30, 2034

    granted

  16. US 8637026

    Anti-C35 antibody combination therapies and methods

    VACCINEX, INC. · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  17. US 8629260

    Anti-arthropod vector vaccines, methods of selecting and uses thereof

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jan 14, 2014 · Expires Jan 9, 2034

    granted

  18. US 8580263

    Anti-EGFR family antibodies, bispecific anti-EGFR family antibodies and methods of use thereof

    The Regents of the University of California · Granted Nov 12, 2013 · Expires Nov 7, 2033

    granted

  19. US 8568721

    Method of treating rheumatoid arthritis with an anti-IL-6R antibody

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 29, 2013 · Expires Oct 24, 2033

    granted

  20. US 8563692

    Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activities

    The Regents of the University of California · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  21. US 8557812

    Small molecule inhibitors of anti-apoptotic BCL-2 family members and the uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 15, 2013 · Expires Oct 10, 2033

    granted

  22. US 8551965

    Anti-viral pyrimidine nucleoside analogues

    University College Cardiff Consultants Limited · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted

  23. US 8535890

    Methods to determine immunogenicity of humanized anti-tag 72 CC49 antibodies

    The United of America as represented by the Secretary of the Department of Health and Human Services · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  24. US 8501688

    SCGB3A2 as a growth factor and anti-apoptotic agent

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.